Pfizer Says Plaintiffs Failed to Plead Causation, Amend Preempted Claims

SAN FRANCISCO - Pfizer Inc. has moved to dismiss federal plaintiffs' amended Bextra and Celebrex complaints, arguing that the plaintiffs fail to allege legally tenable claims and repeat certain allegations that were previously found by the court to be preempted. In Re: Bextra and Celebrex Marketing, Sales Practices and Product Liability Litigation, MDL No. 1699 (N.D. Calif.).

In motion papers filed Nov. 3 in the U.S. District Court for the Northern District of California, Pfizer contends that the amended purchase claims complaints should be dismissed in their entirety with prejudice for failure to allege facts that are essential elements of …